Connor, Clark & Lunn Investment Management (CC&L)’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-38
| Closed | -$26K | – | 983 |
|
|
2017
Q1 | $26K | Hold |
38
| – | – | ﹤0.01% | 883 |
|
|
2016
Q4 | $27K | Hold |
38
| – | – | ﹤0.01% | 867 |
|
|
2016
Q3 | $36K | Hold |
38
| – | – | ﹤0.01% | 812 |
|
|
2016
Q2 | $54K | Hold |
38
| – | – | ﹤0.01% | 831 |
|
|
2016
Q1 | $46K | Hold |
38
| – | – | ﹤0.01% | 800 |
|
|
2015
Q4 | $48K | Buy |
38
+3
| +9% | +$3.79K | ﹤0.01% | 788 |
|
|
2015
Q3 | $50K | Buy |
35
+6
| +21% | +$8.57K | ﹤0.01% | 692 |
|
|
2015
Q2 | $63K | Hold |
29
| – | – | ﹤0.01% | 605 |
|
|
2015
Q1 | $85K | Hold |
29
| – | – | ﹤0.01% | 541 |
|
|
2014
Q4 | $95K | Buy |
29
+1
| +4% | +$3.28K | ﹤0.01% | 552 |
|
|
2014
Q3 | $100K | Hold |
28
| – | – | ﹤0.01% | 523 |
|
|
2014
Q2 | $116K | Hold |
28
| – | – | ﹤0.01% | 505 |
|
|
2014
Q1 | $127K | Buy |
+28
| New | +$127K | ﹤0.01% | 648 |
|
|
2013
Q4 | – | Sell |
-7
| Closed | -$29K | – | 769 |
|
|
2013
Q3 | $29K | Hold |
7
| – | – | ﹤0.01% | 513 |
|
|
2013
Q2 | $74K | Buy |
+7
| New | +$74K | ﹤0.01% | 511 |
|